Bengal Physician Journal

Register      Login

SEARCH WITHIN CONTENT

FIND ARTICLE

Volume / Issue

Online First

Archive
Volume  11 (2024)
Volume  10 (2023)
Volume  9 (2022)
Volume  8 (2021)
Volume  7 (2020)
Volume  6 (2019)
Volume  5 (2018)
Related articles

VOLUME 11 , ISSUE 1 ( January-April, 2024 ) > List of Articles

Original Article

Combination of Hs-CRP and Homocysteine Levels as Predictors of Short-term Outcome in Acute Ischemic Stroke

Gaurab Bhaduri, Chanchal K Jana, Shatavisa Mukherjee, Shambo S Samajdar

Keywords : Acute ischemic stroke, High-sensitive C-reactive protein, Homocysteine, Outcome

Citation Information : Bhaduri G, Jana CK, Mukherjee S, Samajdar SS. Combination of Hs-CRP and Homocysteine Levels as Predictors of Short-term Outcome in Acute Ischemic Stroke. Bengal Physician Journal 2024; 11 (1):8-13.

DOI: 10.5005/jp-journals-10070-8035

License: CC BY-NC 4.0

Published Online: 18-04-2024

Copyright Statement:  Copyright © 2024; The Author(s).


Abstract

Background: Apart from the traditional risk factors associated with stroke, several newer independent risk markers that are promising targets for modification, such as hyperhomocysteinemia, and elevated high-sensitive C-reactive protein (hs-CRP), may contribute significantly to the stroke risk. The role of elevated levels of inflammatory markers in predicting prognosis after a first ischemic stroke has been a gray area. The present study aimed to assess the clinical outcome of acute ischemic stroke patients in particular relation to hs-CRP and homocysteine (Hcy) levels within 48 hours of presentation. Methods: A prospective, observational study was carried out among admitted and diagnosed patients with acute ischemic stroke confirmed by CT/MRI scans where included patients were subjected to detailed history taking using pretested and predesigned pro forma along with thorough clinical examination using CT scan brain (non-contrast)/MRI brain. High-sensitive C-reactive protein and Hcy levels and other blood parameters were done within 48 hrs of hospital admission. Patients were scored based on the National Institute of Health Stroke Scale (NIHSS) at specified time points to assess the clinical outcome. Results were statistically analyzed. Results: Patients of cerebral infarction with elevated hs-CRP had a lower improvement score in contrast to those with non-elevated hs-CRP, who had a higher improvement. Also, patients with an elevated Hcy level had a lower mean improvement score at day 30 compared to those with normal Hcy levels. With the increasing size of the infarct, there was a lower improvement score. The higher the admission NIHSS score, the lower the improvement score in the study. High-sensitive C-reactive protein proved to be the strongest predictor for score improvement with other predictor variables like infarct size, NIHSS baseline score and Hcys also showing positive association. Conclusion: High-sensitive C-reactive protein alone comes out as the strongest predictor for the improvement in NIHSS score from the time of admission to a 30-day progress period with a prediction power of 98%.

PDF Share
  1. The global burden of cerebrovascular disease. Accessed from https://www.who.int/healthinfo/statistics/bod_cerebrovascular diseasestroke.pdf. Accessed on October 10, 2021.
  2. Feigin V, Norrving B, Mensah GA. Global burden of stroke. Circ Res 2017;120:439–448. DOI: 10.1161/CIRCRESAHA.116.308413.
  3. Hui C, Tadi P, Patti L. Ischemic stroke. In: StatPearls. Treasure Island (FL): StatPearls Publishing; 2021. Available from: https://www.ncbi.nlm.nih.gov/books/NBK499997/.
  4. Xing C, Arai K, Lo EH, et al. Pathophysiologic cascades in ischemic stroke. Int J Stroke 2012;7(5):378–385. DOI: 10.1111/j.1747-4949.2012.00839.x.
  5. Matsuo R, Ago T, Hata J, et al. Fukuoka stroke registry investigators. plasma C-reactive protein and clinical outcomes after acute ischemic stroke: A prospective observational study. PLoS One 2016;11(6):e0156790. DOI: 10.1371/journal.pone.0156790.
  6. Carrero JJ, Franko MA, Obergfell A, et al. hsCRP Level and the risk of death or recurrent cardiovascular events in patients with myocardial infarction: A healthcare-based study. J Am Heart Assoc 2019;8(11):e012638. DOI: 10.1161/JAHA.119.012638.
  7. Lehotský J, Tothová B, Kovalská M, et al. Role of homocysteine in the Ischemic stroke and development of Ischemic tolerance. Front Neurosci 2016;10:538. DOI: 10.3389/fnins.2016.00538.
  8. Tinelli C, Di Pino A, Ficulle E, et al. Hyperhomocysteinemia as a risk factor and potential nutraceutical target for certain pathologies. Front Nutr 2019;6:49. DOI: 10.3389/fnut.2019.00049.
  9. Okubadejo NU, Oladipo OO, Adeyomoye AA, et al. Exploratory study of plasma total homocysteine and its relationship to short-term outcome in acute ischaemic stroke in Nigerians. BMC Neurol 2008;8:26. DOI: 10.1186/1471-2377-8-26.
  10. Tawakol A, Omland T, Gerhard M, et al. Hyperhomocysteinemia is associated with impaired endothelium-dependent vasodilation in humans. Circulation 1997;95(5):1119–1121. DOI: 10.1161/01.cir.95.5.1119.
  11. Christen WG, Ajani UA, Glynn RJ, et al. Blood levels of homocysteine and increased risks of cardiovascular disease: Causal or casual? Arch Intern Med 2000;160(4):422–434. DOI: 10.1001/archinte.160.4.422.
  12. Perry IJ, Refsum H, Morris RW, et al. Prospective study of serum total homocysteine concentration and risk of stroke in middle-aged British men. Lancet 1995;346(8987):1395–1398. DOI: 10.1016/s0140-6736(95)92407-8.
  13. Pniewski J, Chodakowska-Zebrowska M, Wozniak R, et al. Plasma homocysteine level and the course of ischaemic stroke. Acta Neurobiol Exp (Wars) 2003;63(2):127–130. DOI: 10.55782/ane-2003-1462.
  14. Cozlea DL, Farcas DM, Nagy A, et al. The impact of C reactive protein on global cardiovascular risk on patients with coronary artery disease. Curr Health Sci J 2013;39(4):225–231. PMID: 24778862.
  15. Osman R, L'Allier PL, Elgharib N, et al. Critical appraisal of C-reactive protein throughout the spectrum of cardiovascular disease. Vasc Health Risk Manag 2006;2(3):221–237. DOI: 10.2147/vhrm.2006.2.3.221.
  16. Chuang CH, Lee YY, Sheud BF, et al. Homocysteine and C-reactive protein as useful surrogate markers for evaluating CKD risk in adults. Kidney Blood Press Res 2013;37(3–4):402–413. DOI: 10.1159/000355722.
  17. Katan M, Luft A. Global burden of stroke. Semin Neurol 2018;38(2): 208–211. DOI: 10.1055/s-0038-1649503.
  18. Jones SP, Baqai K, Clegg A, et al. Stroke in India: A systematic review of the incidence, prevalence, and case fatality. Int J Stroke 2021;17(2):132–140. DOI: 10.1177/17474930211027834.
  19. Arboix A. Cardiovascular risk factors for acute stroke: Risk profiles in the different subtypes of ischemic stroke. World J Clin Cases 2015;3(5):418–429. DOI: 10.12998/wjcc.v3.i5.418.
  20. Taheraghdam A, Aminnejad S, Pashapour A, et al. Is there a correlation between hs-CRP levels and functional outcome of Ischemic Stroke?. Pak J Med Sci 2013;29(1):166–169. DOI: 10.12669/pjms.291.2799.
  21. VanGilder RL, Davidov DM, Stinehart KR, et al. C-reactive protein and long-term ischemic stroke prognosis. J Clin Neurosci 2014;21(4): 547–553. DOI: 10.1016/j.jocn.2013.06.015.
  22. Guillermo. Umpierrez, Scott D. Hyperglycemia an independent marker of in-hospital mortality in patients with undiagnosed diabetes. J of Clin Endo and Metabolism 2002;32:2426–2432. DOI: 10.1210/jcem.87.3.8341.
  23. Kushner M, Nencini P, Reivich M, et al. Relation of hyperglycemia early in ischemic brain infarction to cerebral anatomy, metabolism, and clinical outcome. Ann Neurol 1990;28(2):129–135. DOI: 10.1002/ana.410280204.
  24. Shomanova Z, Ohnewein B, Schernthaner C, et al. Classic and novel biomarkers as potential predictors of ventricular arrhythmias and sudden cardiac death. J Clin Med 2020;9(2):578. DOI: 10.3390/jcm9020578.
  25. Sproston NR, Ashworth JJ. Role of C-reactive protein at sites of inflammation and infection. Front Immunol 2018;9:754. DOI: 10.3389/fimmu.2018.00754.
  26. Chaudhuri JR, Mridula KR, Umamahesh M, et al. High sensitivity C-reactive protein levels in acute ischemic stroke and subtypes: A study from a tertiary care center. Iran J Neurol 2013;12(3):92–97. PMID: 24250912.
  27. Yadav KK, Chaudhary HR. Clinical profile and outcome of stroke in relation to glycemic status of patients. J Indian Med Assoc 2004;102(3):138–139, 142, 150. PMID: 15473273.
  28. Lyden P. Using the national institutes of health stroke scale. A cautionary tale. Stroke 2017;48(2):513–519. DOI: 10.1161/STROKEAHA. 116.015434.
  29. Wouters A, Nysten C, Thijs V, et al. Prediction of outcome in patients with acute ischemic stroke based on initial severity and improvement in the first 24 h. Front Neurol 2018;9:308. DOI: 10.3389/fneur.2018.00308.
  30. Adams HP, Davis PH, Leira EC, et al. Baseline NIH stroke scale score strongly predicts outcome after stroke: A report of the trial of Org 10172 in acute stroke treatment (TOAST). Neurology 1999;53(1): 126–131. DOI: 10.1212/wnl.53.1.126.
  31. Vogt G, Laage R, Shuaib A, et al. Initial lesion volume is an independent predictor of clinical stroke outcome at day 90: An analysis of the Virtual International Stroke Trials Archive (VISTA) database. Stroke 2012;43(5):1266–1272. DOI: 10.1161/STROKEAHA.111.646570.
PDF Share
PDF Share

© Jaypee Brothers Medical Publishers (P) LTD.